Norris Medicines Limited (BOM:524414)
India flag India · Delayed Price · Currency is INR
17.25
+0.17 (1.00%)
At close: Jul 7, 2025

Norris Medicines Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
-12.38-11.87-17.49-32.63-49.62
Upgrade
Depreciation & Amortization
5.375.716.36.576.67
Upgrade
Loss (Gain) From Sale of Assets
-0.22---
Upgrade
Other Operating Activities
4.624.4720.4525.4925.9
Upgrade
Change in Accounts Receivable
-3.410.4-0.086.969.72
Upgrade
Change in Inventory
2.05-11.35-7.7826.82-10.97
Upgrade
Change in Accounts Payable
8.9915.219.21-49.136.53
Upgrade
Change in Other Net Operating Assets
-2.27-1.11.395.81-7.1
Upgrade
Operating Cash Flow
2.991.712-10.0911.14
Upgrade
Operating Cash Flow Growth
75.81%-85.85%---
Upgrade
Capital Expenditures
-0.19-0.01-0.3-0.55-0.88
Upgrade
Sale of Property, Plant & Equipment
-0.91---
Upgrade
Other Investing Activities
6.02-0.390.08-0.340.26
Upgrade
Investing Cash Flow
5.830.51-0.22-0.89-0.62
Upgrade
Long-Term Debt Issued
-1.673.2425.785.4
Upgrade
Long-Term Debt Repaid
-0.64----
Upgrade
Net Debt Issued (Repaid)
-0.641.673.2425.785.4
Upgrade
Other Financing Activities
-4.21-3.7-15-14.82-16.34
Upgrade
Financing Cash Flow
-4.85-2.03-11.7610.96-10.94
Upgrade
Miscellaneous Cash Flow Adjustments
-3.94--0-0
Upgrade
Net Cash Flow
0.020.170.02-0.02-0.43
Upgrade
Free Cash Flow
2.81.6911.7-10.6510.26
Upgrade
Free Cash Flow Growth
65.74%-85.58%---
Upgrade
Free Cash Flow Margin
4.80%2.99%13.99%-11.28%8.37%
Upgrade
Free Cash Flow Per Share
0.280.171.17-1.061.03
Upgrade
Cash Interest Paid
4.213.71514.8216.34
Upgrade
Levered Free Cash Flow
3.492.361.26-18.359.53
Upgrade
Unlevered Free Cash Flow
6.234.6510.56-9.1419.65
Upgrade
Change in Net Working Capital
-6.05-3.63-2.7210.66-28.92
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.